{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:15:52Z","timestamp":1792106152006,"version":"4.4.0"},"reference-count":433,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA726129"],"award-info":[{"award-number":["DA726129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA041781"],"award-info":[{"award-number":["DA041781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA042581"],"award-info":[{"award-number":["DA042581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA042499"],"award-info":[{"award-number":["DA042499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA041883"],"award-info":[{"award-number":["DA041883"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA045463"],"award-info":[{"award-number":["DA045463"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000888","name":"W. M. Keck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Syst. Neurosci."],"abstract":"<jats:p>Decades of research advances have established a central role for endogenous opioid systems in regulating reward processing, mood, motivation, learning and memory, gastrointestinal function, and pain relief. Endogenous opioid systems are present ubiquitously throughout the central and peripheral nervous system. They are composed of four families, namely the \u03bc (MOPR), \u03ba (KOPR), \u03b4 (DOPR), and nociceptin\/orphanin FQ (NOPR) opioid receptors systems. These receptors signal through the action of their endogenous opioid peptides \u03b2-endorphins, dynorphins, enkephalins, and nociceptins, respectfully, to maintain homeostasis under normal physiological states. Due to their prominent role in pain regulation, exogenous opioids\u2014primarily targeting the MOPR, have been historically used in medicine as analgesics, but their ability to produce euphoric effects also present high risks for abuse. The ability of pain and opioid use to perturb endogenous opioid system function, particularly within the central nervous system, may increase the likelihood of developing opioid use disorder (OUD). Today, the opioid crisis represents a major social, economic, and public health concern. In this review, we summarize the current state of the literature on the function, expression, pharmacology, and regulation of endogenous opioid systems in pain. Additionally, we discuss the adaptations in the endogenous opioid systems upon use of exogenous opioids which contribute to the development of OUD. Finally, we describe the intricate relationship between pain, endogenous opioid systems, and the proclivity for opioid misuse, as well as potential advances in generating safer and more efficient pain therapies.<\/jats:p>","DOI":"10.3389\/fnsys.2022.1014768","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:49:11Z","timestamp":1666169351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":92,"title":["Endogenous opioid systems alterations in pain and opioid use disorder"],"prefix":"10.3389","volume":"16","author":[{"given":"Jessica A.","family":"Higginbotham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Massaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/SJ.BJP.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.","volume":"151","author":"Abul-Husn","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/S40122-017-0069-2","article-title":"Genetic testing for opioid pain management: a primer.","volume":"6","author":"Agarwal","year":"2017","journal-title":"Pain Ther."},{"key":"B3","author":"Ahmad","year":"2022","journal-title":"Provisional Drug Overdose Death Counts."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-018-2843-9","article-title":"The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial.","volume":"19","author":"Ahmadi","year":"","journal-title":"Trials"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13063-018-3055-Z\/TABLES\/4","article-title":"Single high-dose buprenorphine for opioid craving during withdrawal.","volume":"19","author":"Ahmadi","year":"","journal-title":"Trials"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0B013E318238BBA6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior.","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","article-title":"Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward.","volume":"87","author":"Al-Hasani","year":"2015","journal-title":"Neuron"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1097\/00001756-199708180-00028","article-title":"Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation.","volume":"8","author":"Andoh","year":"1997","journal-title":"Neuroreport"},{"key":"B9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5055\/JOM.2007.0048","article-title":"Using methadone to treat opioid-induced hyperalgesia and refractory pain.","volume":"3","author":"Axelrod","year":"2007","journal-title":"J. Opioid Manag."},{"key":"B10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.NEURON.2010.03.002","article-title":"Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain.","volume":"66","author":"Baliki","year":"2010","journal-title":"Neuron"},{"key":"B11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/J.PAIN.0000000000000105","article-title":"Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain.","volume":"156","author":"Ballantyne","year":"2015","journal-title":"Pain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1097\/J.PAIN.0000000000001913","article-title":"Will biased ligands be the opioids of the future?","volume":"161","author":"Ballantyne","year":"2020","journal-title":"Pain"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1097\/J.PAIN.0000000000002280","article-title":"Allostasis theory in opioid tolerance.","volume":"162","author":"Ballantyne","year":"2021","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01775-z","article-title":"Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation.","volume":"12","author":"Ballester","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/S13311-020-00887-6","article-title":"Central nervous system targets: supraspinal mechanisms of analgesia.","volume":"17","author":"Bannister","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/S40261-017-0590-4","article-title":"Who receives nalmefene and how does it work in the real world? A single-arm, phase iv study of nalmefene in alcohol dependent outpatients: baseline and 1-month results.","volume":"38","author":"Barrio","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"B17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/ANNUREV.NE.07.030184.001521","article-title":"Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.","volume":"7","author":"Basbaum","year":"1984","journal-title":"Annu. Rev. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/ejn.12829","article-title":"Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.","volume":"41","author":"Beaudry","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/J.EJPAIN.2007.12.007","article-title":"Signal valence in the nucleus accumbens to pain onset and offset.","volume":"12","author":"Becerra","year":"2008","journal-title":"Eur. J. Pain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/J.2042-7158.1954.TB11033.X","article-title":"Synthetic analgesics: stereochemical considerations.","volume":"6","author":"Beckett","year":"1954","journal-title":"J. Pharm. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/08990229009144706","article-title":"Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla.","volume":"7","author":"Bederson","year":"1990","journal-title":"Somatosens. Mot. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0304-3959(02)00266-X","article-title":"Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).","volume":"99","author":"Bencherif","year":"2002","journal-title":"Pain"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-739","article-title":"Risky monetary behavior in chronic back pain is associated with altered modular connectivity of the nucleus accumbens.","volume":"7","author":"Berger","year":"2014","journal-title":"BMC Res. Notes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","article-title":"What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?","volume":"28","author":"Berridge","year":"1998","journal-title":"Brain Res. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0306-4522(03)00484-6","article-title":"[3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain.","volume":"121","author":"Berthele","year":"2003","journal-title":"Neuroscience"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1038\/SJ.NPP.1301370","article-title":"Preproenkephalin knockout mice show no depression-related phenotype.","volume":"32","author":"Bilkei-Gorzo","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/J.1460-9568.2010.07314.X","article-title":"Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.","volume":"32","author":"Billa","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0196-9781(00)00252-7","article-title":"Agonistic effects of the opioid buprenorphine on the nociceptin\/OFQ receptor.","volume":"21","author":"Bloms-Funke","year":"2000","journal-title":"Peptides"},{"key":"B29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/ADM.0b013e3181ba895d","article-title":"A clinical trial comparing tapering doses of buprenorphine with steady doses for chronic pain and coexistent opioid addiction.","volume":"4","author":"Blondell","year":"2010","journal-title":"J. Addict. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/J.JPAIN.2012.05.005","article-title":"Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.","volume":"13","author":"Bobeck","year":"2012","journal-title":"J. Pain"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/J.PEPTIDES.2021.170547","article-title":"Endogenous opiates and behavior: 2019.","volume":"141","author":"Bodnar","year":"2021","journal-title":"Peptides"},{"key":"B32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/35047086","article-title":"\u03bc-Opioid receptor desensitization by \u03b2-arrestin-2 determines morphine tolerance but not dependence.","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking \u03b2-arrestin 2.","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/J.NEUBIOREV.2016.05.033","article-title":"Reward deficiency and anti-reward in pain chronification.","volume":"68","author":"Borsook","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1073\/pnas.93.4.1486","article-title":"Determinants of the G protein-dependent opioid modulation of neuronal calcium channels.","volume":"93","author":"Bourinet","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0014-2999(02)01833-2","article-title":"Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury.","volume":"447","author":"Briscini","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/J.NEURON.2010.11.022","article-title":"Dopamine in motivational control: rewarding, aversive, and alerting.","volume":"68","author":"Bromberg-Martin","year":"2010","journal-title":"Neuron"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0006-8993(90)90066-K","article-title":"Effects of morphine treatment on pro-opiomelanocortin systems in rat brain.","volume":"519","author":"Bronstein","year":"1990","journal-title":"Brain Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.biopsych.2019.06.027","article-title":"Epigenetic mechanisms of opioid addiction.","volume":"87","author":"Browne","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","article-title":"Review A brief history of opiates, opioid peptides, and opioid receptors.","volume":"90","author":"Brownstein","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin \/ kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.","volume":"1314","author":"Bruchas","year":"2009","journal-title":"Brain Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/j.1532-2149.2011.00021.x","article-title":"What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?","volume":"16","author":"Bruehl","year":"2012","journal-title":"Eur. J. Pain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/J.PAIN.2013.06.002","article-title":"Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.","volume":"154","author":"Bruehl","year":"2013","journal-title":"Pain"},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/AJP.0000000000000389","article-title":"Do Resting Plasma \u03b2-endorphin levels predict responses to opioid analgesics?","volume":"33","author":"Bruehl","year":"2017","journal-title":"Clin. J. Pain"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000058","article-title":"Endogenous opioid inhibition of chronic low back pain influences degree of back pain relief following morphine administration.","volume":"39","author":"Bruehl","year":"2014","journal-title":"Reg. Anesth. Pain Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0014-5793(94)00561-3","article-title":"Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a \u03bc, \u03b4 or \u03ba opioid receptor type.","volume":"347","author":"Bunzow","year":"1994","journal-title":"FEBS Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/BPH.12599","article-title":"Positive allosteric modulators of the \u03bc-opioid receptor: a novel approach for future pain medications.","volume":"172","author":"Burford","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.PAIN.2004.07.026","article-title":"Validation of a screener and opioid assessment measure for patients with chronic pain.","volume":"112","author":"Butler","year":"2004","journal-title":"Pain"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/npp.2013.46","article-title":"Pain after discontinuation of morphine treatment is associated with synaptic increase of GluA4-containing AMPAR in the dorsal horn of the spinal cord.","volume":"38","author":"Caba\u00f1ero","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/JNR.24680","article-title":"Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain.","volume":"100","author":"Cahill","year":"","journal-title":"J. Neurosci. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/164_2021_434","article-title":"Kappa opioid signaling at the crossroads of chronic pain and opioid addiction.","volume":"271","author":"Cahill","year":"","journal-title":"Handb. Exp. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0304-3959(02)00333-0","article-title":"Up-regulation and trafficking of \u03b4 opioid receptor in a model of chronic inflammation: implications for pain control.","volume":"101","author":"Cahill","year":"2003","journal-title":"Pain"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1523\/JNEUROSCI.21-19-07598.2001","article-title":"Prolonged morphine treatment targets \u03b4 opioid receptors to neuronal plasma membranes and enhances \u03b4-mediated antinociception.","volume":"21","author":"Cahill","year":"2001","journal-title":"J. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/FBP.0B013E3283618AC8","article-title":"Changes in morphine reward in a model of neuropathic pain.","volume":"24","author":"Cahill","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/DA.22500","article-title":"Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials.","volume":"33","author":"Carlezon","year":"2016","journal-title":"Depress Anxiety"},{"key":"B56","year":"2018","journal-title":"CDC\/NCHS, National Vital Statistics System, Mortality."},{"key":"B57","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","article-title":"Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine.","volume":"92","author":"C\u00e9l\u00e8rier","year":"2000","journal-title":"Anesthesiology"},{"key":"B58","year":"2019","journal-title":"SAMHSA, National Survey on Drug Use and Health. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00466","article-title":"Sex differences in kappa opioid receptor function and their potential impact on addiction.","volume":"9","author":"Chartoff","year":"2015","journal-title":"Front. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/npp.2013.171","article-title":"Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion.","volume":"38","author":"Chefer","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/npp.2008.128","article-title":"Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice.","volume":"34","author":"Chefer","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B62","first-page":"8","article-title":"Molecular cloning and functional expression of a mu-opioid receptor from rat brain.","volume":"44","author":"Chen","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop.","volume":"162","author":"Chou","year":"2015","journal-title":"Am. College Phys."},{"key":"B64","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/AJP.0b013e31816b2f43","article-title":"Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations.","volume":"24","author":"Chu","year":"2008","journal-title":"Clin. J. Pain"},{"key":"B65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.PHARMTHERA.2013.06.003","article-title":"Delta opioid receptors in brain function and diseases.","volume":"140","author":"Chu Sin Chung","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/pds.4619","article-title":"Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: a retrospective cohort study.","volume":"28","author":"Chung","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B67","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/jpet.106.103960","article-title":"Endogenous orphanin FQ\/nociceptin is involved in the development of morphine tolerance.","volume":"318","author":"Chung","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-2999(00)00590-2","article-title":"Effect of nociceptin\/orphanin FQ on the rewarding properties of morphine.","volume":"404","author":"Ciccocioppo","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/S00213-003-1645-1","article-title":"Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin\/orphanin FQ in alcohol-preferring rats.","volume":"172","author":"Ciccocioppo","year":"2004","journal-title":"Psychopharmacology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/S002130050828","article-title":"Effect of nociceptin on alcohol intake in alcohol-preferring rats.","volume":"141","author":"Ciccocioppo","year":"1999","journal-title":"Psychopharmacology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/J.DRUGALCDEP.2018.09.007","article-title":"Understanding the use of diverted buprenorphine.","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"B72","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/J.1601-183X.2012.00785.X","article-title":"Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.","volume":"11","author":"Clarke","year":"2012","journal-title":"Genes Brain Behav."},{"key":"B73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0024-3205(82)90402-7","article-title":"Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat.","volume":"31","author":"Colpaert","year":"1982","journal-title":"Life Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3959(00)00413-9","article-title":"Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats.","volume":"91","author":"Colpaert","year":"2001","journal-title":"Pain"},{"key":"B75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: concerns and strategies.","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4165.e6","DOI":"10.1016\/j.molcel.2021.07.033","article-title":"Molecular insights into the biased signaling mechanism of the \u03bc-opioid receptor.","volume":"81","author":"Cong","year":"2021","journal-title":"Mol. Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/J.CONB.2004.05.005","article-title":"Mu opioid receptor: a gateway to drug addiction.","volume":"14","author":"Contet","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"B78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuropharm.2018.12.002","article-title":"Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.","volume":"146","author":"Conway","year":"2019","journal-title":"Neuropharmacology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain.","volume":"41","author":"Corder","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nm.4262","article-title":"Loss of \u03bc opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.","volume":"23","author":"Corder","year":"2017","journal-title":"Nat. Med."},{"key":"B81","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1213\/00000539-198507000-00005","article-title":"Effects of halothane and fentanyl anesthesia on plasma \u03b2-endorphin immunoreactivity during cardiac surgery.","volume":"64","author":"Cork","year":"1985","journal-title":"Anesth. Analg."},{"key":"B82","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1073\/PNAS.73.6.1821","article-title":"Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin.","volume":"73","author":"Cox","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B84","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugalcdep.2012.06.023","article-title":"Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations.","volume":"127","author":"Crist","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"B85","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/NN.3622","article-title":"Targeted expression of \u03bc-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward.","volume":"17","author":"Cui","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/J.YNPAI.2019.100042","article-title":"High trait impulsivity potentiates the effects of chronic pain on impulsive behavior.","volume":"7","author":"Cunha","year":"2020","journal-title":"Neurobiol. Pain"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/J.PAIN.0000000000001513","article-title":"Nociceptin\/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia.","volume":"160","author":"Dagnino","year":"2019","journal-title":"Pain"},{"key":"B88","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/ALN.0000000000003441","article-title":"Benefit and risk evaluation of biased \u03bc-receptor agonist oliceridine versus morphine.","volume":"133","author":"Dahan","year":"2020","journal-title":"Anesthesiology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ACN3.65","article-title":"\u03bc-Opioid activation in the prefrontal cortex in migraine attacks \u2013 brief report I.","volume":"1","author":"DaSilva","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/SJ.NPP.1301529","article-title":"Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.","volume":"33","author":"David","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B92","first-page":"1048","article-title":"d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.","volume":"289","author":"Davis","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3122\/JABFM.2017.04.170112","article-title":"Prescription opioid use among adults with mental health disorders in the United States.","volume":"30","author":"Davis","year":"2017","journal-title":"J. Am. Board Fam. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/1073858403259950","article-title":"Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance\/hyperalgesia.","volume":"10","author":"DeLeo","year":"2004","journal-title":"Neuroscientist"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1046\/J.1460-9568.2003.02676.X","article-title":"Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor.","volume":"17","author":"Depner","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25194493","article-title":"Heteromerization of endogenous mu and delta opioid receptors induces ligand-selective co-targeting to lysosomes.","volume":"25","author":"Derouiche","year":"2020","journal-title":"Molecules"},{"key":"B97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-8993(96)00476-3","article-title":"The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion.","volume":"727","author":"Devine","year":"1996","journal-title":"Brain Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1523\/jneurosci.14-04-01978.1994","article-title":"Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats.","volume":"14","author":"Devine","year":"1994","journal-title":"J. Neurosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphines.","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/ALN.0000000000003120","article-title":"Supraspinal opioid circuits differentially modulate spinal neuronal responses in neuropathic rats.","volume":"132","author":"Dickenson","year":"2020","journal-title":"Anesthesiology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0304-3959(90)91166-G","article-title":"Intrathecal etorphine, fentanyl and buprenorphine on spinal nociceptive neurones in the rat.","volume":"42","author":"Dickenson","year":"1990","journal-title":"Pain"},{"key":"B102","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/BJA\/AER115","article-title":"Opioid receptor subtypes: fact or artifact?","volume":"107","author":"Dietis","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"B103","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/JAMA.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (Heroin) addiction: a clinical trial with methadone hydrochloride.","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1001\/JAMA.1976.03260450029025","article-title":"Methadone maintenance treatment: a ten-year perspective.","volume":"235","author":"Dole","year":"1976","journal-title":"JAMA"},{"key":"B105","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1124\/MOL.112.084632","article-title":"Cellular mechanisms of nociceptin\/orphanin FQ (N\/OFQ) Peptide (NOP) receptor regulation and heterologous regulation by N\/OFQ.","volume":"83","author":"Donica","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/S13311-020-00905-7","article-title":"Central nervous system targets: glial cell mechanisms in chronic pain.","volume":"17","author":"Donnelly","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-74","article-title":"Reduced basal ganglia \u03bc-opioid receptor availability in trigeminal neuropathic pain: a pilot study.","volume":"8","author":"DosSantos","year":"2012","journal-title":"Mol. Pain"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00790","article-title":"Reward circuitry plasticity in pain perception and modulation.","volume":"8","author":"DosSantos","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a039362","article-title":"Opioid-induced molecular and cellular plasticity of ventral tegmental area dopamine neurons.","volume":"11","author":"Doyle","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/SCIENCE.1171759\/SUPPL_FILE\/DRDLA.SOM.PDF","article-title":"Induction of synaptic long-term potentiation after opioid withdrawal.","volume":"325","author":"Drdla","year":"2009","journal-title":"Science"},{"key":"B111","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1126\/SCIENCE.1211726\/SUPPL_FILE\/DRDLA-SCHUTTING.SOM.PDF","article-title":"Erasure of a spinal memory trace of pain by a brief, high-dose opioid administration.","volume":"335","author":"Drdla-Schutting","year":"2012","journal-title":"Science"},{"key":"B112","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1590\/S0034-70942005000100015","article-title":"Opium and opioids: a brief history.","volume":"55","author":"Duarte","year":"2005","journal-title":"Rev. Bras. Anestesiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/00000542-198212000-00006","article-title":"Effects of fentanyl on the response of plasma beta-endorphin immunoreactivity to surgery.","volume":"57","author":"Dubois","year":"1982","journal-title":"Anesthesiology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1208\/s12248-008-9056-1","article-title":"Opioid tolerance development: a pharmacokinetic\/pharmacodynamic perspective.","volume":"10","author":"Dumas","year":"2008","journal-title":"AAPS J."},{"key":"B115","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.biopsych.2008.02.004","article-title":"Dysregulation of nociceptin\/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.","volume":"64","author":"Economidou","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"B116","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/npp.2016.131","article-title":"Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling.","volume":"42","author":"Eidson","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.peptides.2019.01.003","article-title":"Inflammatory mediators of opioid tolerance: implications for dependency and addiction.","volume":"115","author":"Eidson","year":"2019","journal-title":"Peptides"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1097\/j.pain.0000000000002286","article-title":"Do endogenous opioids mediate or fine-tune human pain relief?","volume":"162","author":"Eikemo","year":"2021","journal-title":"Pain"},{"key":"B119","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction.","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"key":"B120","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-neuro-110719-095912","article-title":"Endogenous opioids at the intersection of opioid addiction, pain, and depression: the search for a precision medicine approach.","volume":"43","author":"Emery","year":"2020","journal-title":"Annu. Rev. Neurosci."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2020.00057\/BIBTEX","article-title":"Crosstalk between kappa opioid and dopamine systems in compulsive behaviors.","volume":"11","author":"Escobar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression.","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"B123","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/ALN.0b013e31820a4edb","article-title":"Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain.","volume":"114","author":"Ewan","year":"2011","journal-title":"Anesthesiology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/2049463720973703","article-title":"Adverse effects of COVID-19-related lockdown on pain, physical activity and psychological well-being in people with chronic pain.","volume":"15","author":"Fallon","year":"2021","journal-title":"Br. J. Pain"},{"key":"B125","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/J.PHRS.2004.05.002","article-title":"Methadone\u2014metabolism, pharmacokinetics and interactions.","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol. Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1523\/jneurosci.07-12-03888.1987","article-title":"The role of dopamine in intracranial self-stimulation of the ventral tegmental area.","volume":"7","author":"Fibiger","year":"1987","journal-title":"J. Neurosci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for \u03b4- and \u03bc-opioid receptors exhibit opposing alterations of emotional responses.","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017.","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0006-8993(00)02669-X","article-title":"Autoradiographic localization of [3H]nociceptin binding sites in the rat brain.","volume":"880","author":"Florin","year":"2000","journal-title":"Brain Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/npp.2015.313","article-title":"Dopamine depletion reduces food-related reward activity independent of BMI.","volume":"41","author":"Frank","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0304-3959(02)00469-4","article-title":"Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla.","volume":"104","author":"Friedrich","year":"2003","journal-title":"Pain"},{"key":"B132","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.1523\/JNEUROSCI.0988-20.2020","article-title":"Dissecting the role of GABA neurons in the VTA versus SNr in opioid reward.","volume":"40","author":"Galaj","year":"2020","journal-title":"J. Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/J.JPAIN.2012.03.009","article-title":"The economic costs of pain in the United States.","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/J.1460-9568.2008.06223.X","article-title":"Inflammatory pain is enhanced in delta opioid receptor-knockout mice.","volume":"27","author":"Gav\u00e9riaux-Ruff","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/J.PAIN.2010.12.031","article-title":"Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.","volume":"152","author":"Gaveriaux-Ruff","year":"2011","journal-title":"Pain"},{"key":"B136","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/J.NEUROSCIENCE.2006.08.077","article-title":"Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.","volume":"144","author":"Gendron","year":"","journal-title":"Neuroscience"},{"key":"B137","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/J.NEUROSCIENCE.2007.09.060","article-title":"Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.","volume":"150","author":"Gendron","year":"","journal-title":"Neuroscience"},{"key":"B138","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1523\/JNEUROSCI.3598-05.2006","article-title":"Morphine and pain-related stimuli enhance cell surface availability of somatic \u03b4-opioid receptors in rat dorsal root ganglia.","volume":"26","author":"Gendron","year":"2006","journal-title":"J. Neurosci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1523\/jneurosci.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by \u03bc-opioid and \u03ba-opioid receptors.","volume":"22","author":"Ghozland","year":"2002","journal-title":"J. Neurosci."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain.","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B141","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1073\/PNAS.0307601101","article-title":"A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.","volume":"101","author":"Gomes","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14224","article-title":"The novel \u03bc-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception.","volume":"175","author":"Graeme Henderson","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/J.PAIN.0000000000000762","article-title":"Sociodemographic disparities in chronic pain, based on 12-year longitudinal data.","volume":"158","author":"Grol-Prokopczyk","year":"2017","journal-title":"Pain"},{"key":"B144","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/S40122-019-00143-6\/TABLES\/2","article-title":"A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain.","volume":"9","author":"Gudin","year":"2020","journal-title":"Pain Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.NEULET.2012.05.042","article-title":"Striatal \u03bc-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.","volume":"521","author":"Hagelberg","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1097\/J.PAIN.0000000000000650","article-title":"Disproportionate longer-term opioid use among US adults with mood disorders.","volume":"157","author":"Halbert","year":"2016","journal-title":"Pain"},{"key":"B147","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1192\/BJP.130.3.298","article-title":"Peptides with morphine-like action in the brain.","volume":"130","author":"Hans","year":"1977","journal-title":"Br. J. Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0304-3959(98)00071-2","article-title":"Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin\/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation.","volume":"76","author":"Hao","year":"1998","journal-title":"Pain"},{"key":"B149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/CLPT.1986.159","article-title":"Naloxone, fentanyl, and diazepam modify plasma beta-endorphin levels during surgery.","volume":"40","author":"Hargreaves","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"key":"B150","doi-asserted-by":"publisher","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2849-07.2007","article-title":"Neurobiology of disease decreased central-opioid receptor availability in fibromyalgia.","volume":"27","author":"Harris","year":"2007","journal-title":"J. Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0306-4522(93)90465-R","article-title":"Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue.","volume":"55","author":"Hassan","year":"1993","journal-title":"Neuroscience"},{"key":"B152","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/J.JPAIN.2008.10.003","article-title":"Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.","volume":"10","author":"Hay","year":"2009","journal-title":"J. Pain"},{"key":"B153","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0014-2999(85)90186-4","article-title":"Effect of \u03bc and \u03ba opioid receptor agonists on rat plasma corticosterone levels.","volume":"116","author":"Hayes","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.04.1141","article-title":"PMS31 impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses, and alcohol and non-opioid drug-related overdoses: a retrospective cohort study.","volume":"22","author":"Hayes","year":"2019","journal-title":"Value Health"},{"key":"B155","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/j.pain.0000000000001784","article-title":"Impact of opioid dose escalation on pain intensity.","volume":"161","author":"Hayes","year":"2020","journal-title":"Pain"},{"key":"B156","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","article-title":"Differential opioid tolerance and opioid-induced hyperalgesiaa clinical reality.","volume":"124","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"16748","DOI":"10.1523\/JNEUROSCI.3491-11.2011","article-title":"Distinct mechanisms underlying pronociceptive effects of opioids.","volume":"31","author":"Heinl","year":"2011","journal-title":"J. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1152\/JN.00411.2004\/ASSET\/IMAGES\/LARGE\/Z9K0100441300007.JPEG","article-title":"Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla.","volume":"92","author":"Heinricher","year":"2004","journal-title":"J. Neurophysiol."},{"key":"B159","first-page":"1","author":"Hertz","year":"2018","journal-title":"FDA Briefing Document Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting."},{"key":"B160","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/ADD.14768","article-title":"Comparison of psychiatric comorbidity in treatment-seeking, opioid-dependent patients with versus without chronic pain.","volume":"115","author":"Higgins","year":"2020","journal-title":"Addiction"},{"key":"B161","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/J.NEUROPHARM.2008.05.012","article-title":"Shell\/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.","volume":"55","author":"Hip\u00f3lito","year":"2008","journal-title":"Neuropharmacology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"12217","DOI":"10.1523\/JNEUROSCI.1053-15.2015","article-title":"Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area \u03bc opioid receptors.","volume":"35","author":"Hip\u00f3lito","year":"2015","journal-title":"J. Neurosci."},{"key":"B163","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.NEUROSCIENCE.2005.03.065","article-title":"Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.","volume":"135","author":"Hirose","year":"2005","journal-title":"Neuroscience"},{"key":"B164","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/J.EJPAIN.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: a literature review.","volume":"11","author":"H\u00f8jsted","year":"2007","journal-title":"Eur. J. Pain"},{"key":"B165","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/306611a0","article-title":"Isolation and structural organization of the human preproenkephalin Bgene.","volume":"306","author":"Horikawa","year":"1983","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/J.JSAT.2017.03.006","article-title":"Chronic pain among patients with opioid use disorder: results from electronic health records data.","volume":"77","author":"Hser","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"B167","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1476-5381.1977.tb07557.x","article-title":"The distribution of methionin-enkephalin in the brain and peripheral tissues.","volume":"61","author":"Hughes","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/09540261.2018.1514295","article-title":"Systematic review of sex-based differences in opioid-based effects.","volume":"30","author":"Huhn","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"B169","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/SJ.MP.4000319","article-title":"Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects.","volume":"2","author":"Hurd","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"B170","author":"Hutchings","year":"1997","journal-title":"References and Notes Enhanced Morphine Analgesia in Mice Lacking-Arrestin 2."},{"key":"B171","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0304-3959(88)90141-8","article-title":"Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding.","volume":"35","author":"Iadarola","year":"1988","journal-title":"Pain"},{"key":"B172","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0168-0102(00)00144-9","article-title":"Involvement of G-protein-activated inwardly rectifying K+ (GIRK) channels in opioid-induced analgesia.","volume":"38","author":"Ikeda","year":"2000","journal-title":"Neurosci. Res."},{"key":"B173","year":"2011","journal-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research."},{"key":"B174","first-page":"429","article-title":"Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.","volume":"238","author":"Iyengar","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B175","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/PAPR.13001","article-title":"Prevalence of problematic use of opioids in patients with chronic noncancer pain: a systematic review with meta-analysis.","volume":"21","author":"Jantarada","year":"2021","journal-title":"Pain Pract."},{"key":"B176","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/J.PAIN.2012.01.002","article-title":"Pain, affective symptoms and cognitive deficits in patients with cerebral dopamine dysfunction.","volume":"153","author":"Jarcho","year":"2012","journal-title":"Pain"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101905","article-title":"Impact of chronic migraine attacks and their severity on the endogenous \u03bc-opioid neurotransmission in the limbic system.","volume":"23","author":"Jassar","year":"2019","journal-title":"Neuroimage Clin."},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2021.642493\/BIBTEX","article-title":"The role of the kappa opioid system in comorbid pain and psychiatric disorders: function and implications.","volume":"15","author":"Ji","year":"2021","journal-title":"Front. Neurosci."},{"key":"B179","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder.","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B180","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejphar.2005.12.002","article-title":"Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.","volume":"531","author":"Jutkiewicz","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/J.PAIN.2006.08.003","article-title":"Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain.","volume":"127","author":"Kabli","year":"2007","journal-title":"Pain"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1073\/pnas.1915143117\/-\/DCSupplemental","article-title":"Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA\u2013GABA transmission in highly addicted rats.","volume":"117","author":"Kallupi","year":"2020","journal-title":"Natl. Acad. Sci."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1523\/jneurosci.11-05-01433.1991","article-title":"Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla.","volume":"11","author":"Kaplan","year":"1991","journal-title":"J. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134550","article-title":"Sex differences in dose escalation and overdose death during chronic opioid therapy: a population-based cohort study.","volume":"10","author":"Kaplovitch","year":"2015","journal-title":"PLoS One"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.4088\/JCP.13M08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"B186","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/S00210-006-0033-X","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1176\/APPI.AJP.160.4.687","article-title":"Specificity of genetic and environmental risk factors for use and abuse\/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.","volume":"160","author":"Kendler","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"B188","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1073\/PNAS.89.24.12048","article-title":"The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B189","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1111\/BPH.15004","article-title":"Morphine-induced respiratory depression is independent of \u03b2-arrestin2 signalling.","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased \u03bc-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nat. Commun."},{"key":"B191","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jpain.2008.11.006","article-title":"Antinociceptive effects of nociceptin\/orphanin FQ administered intrathecally in monkeys.","volume":"10","author":"Ko","year":"2009","journal-title":"J. Pain"},{"key":"B192","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/J.PHARMTHERA.2007.10.003","article-title":"Role of receptor internalization in opioid tolerance and dependence.","volume":"117","author":"Koch","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"B193","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement.","volume":"87","author":"Koob","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"B194","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2010.4","article-title":"Neurocircuitry of addiction.","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.PAIN.2005.06.030","article-title":"Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.","volume":"118","author":"Koppert","year":"2005","journal-title":"Pain"},{"key":"B196","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0014-2999(03)02081-8","article-title":"Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats.","volume":"474","author":"Kotlinska","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00008877-200205000-00006","article-title":"Orphanin FQ\/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference.","volume":"13","author":"Kotli\u00f1ska","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0304-3959(00)00290-6","article-title":"Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.","volume":"87","author":"Kovelowski","year":"2000","journal-title":"Pain"},{"key":"B199","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","article-title":"Medical safety and side effects of methadone in tolerant individuals.","volume":"223","author":"Kreek","year":"1973","journal-title":"JAMA"},{"key":"B200","first-page":"245","author":"Kreek","year":"1991","journal-title":"Using Methadone Effectively: Achieving Goals by Application of Laboratory, Clinical, and Evaluation Research and by Development of Innovative Programs."},{"key":"B201","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1749-6632.2000.tb06683.x","article-title":"Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine.","volume":"909","author":"Kreek","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the treatment of addiction: methadone.","volume":"29","author":"Kreek","year":"2010","journal-title":"J. Addict. Dis."},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5049.193696","article-title":"The isolation of morphine by Serturner.","volume":"60","author":"Krishnamurti","year":"2016","journal-title":"Indian J. Anaesth."},{"key":"B204","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/sj.bjp.0705583","article-title":"Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors.","volume":"141","author":"Kuzmin","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/J.NEUROSCIENCE.2004.01.023","article-title":"Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the ventrolateral periaqueductal gray.","volume":"125","author":"Lane","year":"2004","journal-title":"Neuroscience"},{"key":"B206","doi-asserted-by":"publisher","first-page":"150","DOI":"10.15585\/mmwr.rr6501e1er","article-title":"CDC issues new opioid prescribing guideline.","volume":"48","author":"Lappin","year":"2016","journal-title":"Emerg. Med."},{"key":"B207","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/ajad.13153","article-title":"Chronic pain among patients with an opioid use disorder.","volume":"30","author":"Latif","year":"2021","journal-title":"Am. J. Addict."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1523\/JNEUROSCI.4592-13.2014","article-title":"\u03b4-Opioid and dopaminergic processes in accumbens shell modulate the cholinergic control of predictive learning and choice.","volume":"34","author":"Laurent","year":"2014","journal-title":"J. Neurosci."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1523\/JNEUROSCI.4688-11.2012","article-title":"\u03bc- and \u03b4-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice.","volume":"32","author":"Laurent","year":"2012","journal-title":"J. Neurosci."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain.","volume":"89","author":"le Merrer","year":"2009","journal-title":"Physiol. Rev."},{"key":"B211","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/J.BIOPSYCH.2010.10.021","article-title":"Deletion of the \u03b4 opioid receptor gene impairs place conditioning but preserves morphine reinforcement.","volume":"69","author":"le Merrer","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"B212","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/S11916-010-0103-0","article-title":"Unravelling the mystery of pain, suffering, and relief with brain imaging.","volume":"14","author":"Lee","year":"2010","journal-title":"Curr. Pain Headache Rep."},{"key":"B213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A comprehensive review of opioid-induced hyperalgesia.","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Phys."},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0017870","article-title":"Relief as a reward: hedonic and neural responses to safety from pain.","volume":"6","author":"Leknes","year":"2011","journal-title":"PLoS One"},{"key":"B215","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/NRN2333","article-title":"A common neurobiology for pain and pleasure.","volume":"9","author":"Leknes","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"B216","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/EPI.14.75","article-title":"Epigenetic regulation of chronic pain.","volume":"7","author":"Liang","year":"2015","journal-title":"Epigenomics"},{"key":"B217","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/S11302-016-9525-4\/FIGURES\/7","article-title":"Morphine enhances IL-1\u03b2 release through toll-like receptor 4-mediated endocytic pathway in microglia.","volume":"12","author":"Liang","year":"2016","journal-title":"Purinergic Signal"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/0024-3205(89)90272-5","article-title":"Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model.","volume":"45","author":"Ling","year":"1989","journal-title":"Life Sci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1124\/JPET.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist.","volume":"349","author":"Linz","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B220","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Neurobiology of disease kappa opioid receptors drive a tonic aversive component of chronic pain.","volume":"39","author":"Liu","year":"2019","journal-title":"J. Neurosci."},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1111\/BPH.13823","article-title":"Allostery at opioid receptors: modulation with small molecule ligands.","volume":"175","author":"Livingston","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1007\/s12035-018-1361-9","article-title":"Opioid activity in the locus coeruleus is modulated by chronic neuropathic pain.","volume":"56","author":"Llorca-Torralba","year":"","journal-title":"Mol. Neurobiol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.biopsych.2019.02.018","article-title":"Chemogenetic silencing of the locus coeruleus\u2013basolateral amygdala pathway abolishes pain-induced anxiety and enhanced aversive learning in rats.","volume":"85","author":"Llorca-Torralba","year":"","journal-title":"Biol. Psychiatry"},{"key":"B224","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/267495a0","article-title":"Endogenous opioid peptides: multiple agonists and receptors.","volume":"267","author":"Lord","year":"1977","journal-title":"Nature"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/J.1460-9568.2008.06100.X","article-title":"Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat.","volume":"27","author":"Loyd","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.15620\/CDC:107894","article-title":"Back, lower limb, and upper limb pain among U.S. Adults, 2019.","author":"Lucas","year":"2021","journal-title":"NCHS Data Brief"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00886","article-title":"The contribution of the descending pain modulatory pathway in opioid tolerance.","volume":"12","author":"Lueptow","year":"2018","journal-title":"Front. Neurosci."},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology.","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130000609","article-title":"Orphanin FQ\/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats.","volume":"154","author":"Lutfy","year":"","journal-title":"Psychopharmacology"},{"key":"B230","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/SJ.BJP.0704279","article-title":"Orphanin FQ\/nociceptin attenuates the development of morphine tolerance in rats.","volume":"134","author":"Lutfy","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/0024-3205(89)90062-3","article-title":"Morphine self-administration in the rat during adjuvant-induced arthritis.","volume":"45","author":"Lyness","year":"1989","journal-title":"Life Sci."},{"key":"B232","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/JPET.109.152157","article-title":"Extracellular signal-regulated kinase 1\/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat.","volume":"331","author":"Macey","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B233","doi-asserted-by":"publisher","first-page":"34515","DOI":"10.1074\/JBC.M604278200","article-title":"Mu Opioid Receptor Activation of ERK1\/2 Is GRK3 and arrestin dependent in striatal neurons.","volume":"281","author":"Macey","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/J.JPAIN.2017.07.008","article-title":"Chronic opioid therapy modifies QST changes after ketamine infusion in chronic pain patients.","volume":"18","author":"Maher","year":"2017","journal-title":"J. Pain"},{"key":"B235","doi-asserted-by":"publisher","first-page":"10015","DOI":"10.1073\/PNAS.1918682117","article-title":"Loss of nucleus accumbens low-frequency fluctuations is a signature of chronic pain.","volume":"117","author":"Makary","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B236","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/S40122-021-00243-2","article-title":"COVID-19 and the opioid epidemic: two public health emergencies that intersect with chronic pain.","volume":"10","author":"Manchikanti","year":"2021","journal-title":"Pain Ther."},{"key":"B237","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects.","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000086","article-title":"Sex differences among opioid-abusing chronic pain patients in a clinical trial.","volume":"9","author":"Manubay","year":"2015","journal-title":"J. Addict. Med."},{"key":"B239","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1523\/JNEUROSCI.22-18-08312.2002","article-title":"Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.","volume":"22","author":"Mao","year":"2002","journal-title":"J. Neurosci."},{"key":"B240","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/J.RDC.2008.04.003","article-title":"The physiology of pain mechanisms: from the periphery to the brain.","volume":"34","author":"Marchand","year":"2008","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"B241","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events.","volume":"103","author":"Mark","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41593-021-00924-3","article-title":"Pain induces adaptations in ventral tegmental area dopamine neurons to drive anhedonia-like behavior.","volume":"24","author":"Markovic","year":"2021","journal-title":"Nat. Neurosci."},{"key":"B243","doi-asserted-by":"publisher","first-page":"9957","DOI":"10.1523\/JNEUROSCI.4605-14.2015","article-title":"Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum.","volume":"35","author":"Martikainen","year":"2015","journal-title":"J. Neurosci."},{"key":"B244","doi-asserted-by":"publisher","first-page":"14729","DOI":"10.1523\/JNEUROSCI.1400-13.2013","article-title":"Alterations in endogenous opioid functional measures in chronic back pain.","volume":"33","author":"Martikainen","year":"2013","journal-title":"J. Neurosci."},{"key":"B245","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/00000542-200702000-00020","article-title":"Opioid Self-administration in the nerve-injured ratrelevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.","volume":"106","author":"Martin","year":"2007","journal-title":"Anesthesiology"},{"key":"B246","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/J.PAIN.2006.05.027","article-title":"Clonidine maintains intrathecal self-administration in rats following spinal nerve ligation.","volume":"125","author":"Martin","year":"2006","journal-title":"Pain"},{"key":"B247","first-page":"517","article-title":"The effects of morphine and nalorphine like drugs in the nondependent and morphine dependent chronic spinal dog.","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B248","doi-asserted-by":"publisher","first-page":"564.e6","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system.","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"B249","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/BS.IRN.2020.09.002","article-title":"Pain, negative affective states and opioid-based analgesics: safer pain therapies to dampen addiction.","volume":"157","author":"Massaly","year":"2021","journal-title":"Int. Rev. Neurobiol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cobeha.2018.10.002","article-title":"Pain and opioid systems, implications in the opioid epidemic.","volume":"26","author":"Massaly","year":"2019","journal-title":"Curr. Opin. Behav. Sci."},{"key":"B251","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1097\/J.PAIN.0000000000001968","article-title":"Uncovering the analgesic effects of a pH-dependent mu-opioid receptor agonist using a model of nonevoked ongoing pain.","volume":"161","author":"Massaly","year":"2020","journal-title":"Pain"},{"key":"B252","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/J.NEURON.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal.","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2020.30676","article-title":"The importance of studying sex and gender differences in opioid misuse.","volume":"3","author":"McHugh","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.2908","article-title":"Assessment of opioid prescribing practices before and after implementation of a health system intervention to reduce opioid overprescribing.","volume":"1","author":"Meisenberg","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"B256","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"B257","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/J.NEUROPHARM.2007.03.002","article-title":"Analgesic tolerance to microinjection of the \u03bc-opioid agonist DAMGO into the ventrolateral periaqueductal gray.","volume":"52","author":"Meyer","year":"2007","journal-title":"Neuropharmacology"},{"key":"B258","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0006-8993(85)90786-3","article-title":"Spinal cord dynorphin may modulate nociception via a kappa-opioid receptor in chronic arthritic rats.","volume":"340","author":"Millan","year":"1985","journal-title":"Brain Res."},{"key":"B259","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0304-3959(88)90140-6","article-title":"Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.","volume":"35","author":"Millan","year":"1988","journal-title":"Pain"},{"key":"B260","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1523\/jneurosci.07-01-00077.1987","article-title":"A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems.","volume":"7","author":"Millan","year":"1987","journal-title":"J. Neurosci."},{"key":"B261","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/J.1360-0443.2012.04005.X","article-title":"Development of dependence following treatment with opioid analgesics for pain relief: a systematic review.","volume":"108","author":"Minozzi","year":"2013","journal-title":"Addiction"},{"key":"B262","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2016.05.017","article-title":"Modulation of pain, nociception, and analgesia by the brain reward center.","volume":"338","author":"Mitsi","year":"2016","journal-title":"Neuroscience"},{"key":"B263","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/J.CELREP.2013.10.015","article-title":"Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and \u03b2-arrestin 1 pathway.","volume":"5","author":"Mittal","year":"2013","journal-title":"Cell Rep."},{"key":"B264","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/PCN.12914","article-title":"Nalmefene in alcohol-dependent patients with a high drinking risk: randomized controlled trial.","volume":"73","author":"Miyata","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B265","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/J.TIG.2012.02.004","article-title":"Pain genetics: past, present and future.","volume":"28","author":"Mogil","year":"2012","journal-title":"Trends Genet."},{"key":"B266","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0306-4522(96)00338-7","article-title":"Orphanin FQ is a functional anti-opioid peptide.","volume":"75","author":"Mogil","year":"","journal-title":"Neuroscience"},{"key":"B267","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0304-3940(96)12917-7","article-title":"Functional antagonism of \u03bc-, \u03b4- and \u03ba-opioid antinociception by orphanin FQ.","volume":"214","author":"Mogil","year":"","journal-title":"Neurosci. Lett."},{"key":"B268","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jnr.24770","article-title":"Cellular and behavioral basis of cannabinioid and opioid interactions: implications for opioid dependence and withdrawal.","volume":"100","author":"Mohammadkhani","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"B269","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Lett."},{"key":"B270","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/J.PAIN.2010.10.009","article-title":"Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder.","volume":"152","author":"Morasco","year":"2011","journal-title":"Pain"},{"key":"B271","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/ANNUREV.CELLBIO.13.1.261","article-title":"Cyclin-dependent kinases: engines, clocks, and microprocessors.","volume":"13","author":"Morgan","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/J.PBB.2006.08.003","article-title":"Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat.","volume":"85","author":"Morgan","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B273","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1523\/JNEUROSCI.2719-03.2004","article-title":"Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord.","volume":"24","author":"Morinville","year":"","journal-title":"J. Neurosci."},{"key":"B274","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.pain.2004.01.011","article-title":"Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.","volume":"109","author":"Morinville","year":"","journal-title":"Pain"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.clinthera.2013.10.001","article-title":"Pain as the fifth vital sign: exposing the vital need for pain education.","volume":"35","author":"Morone","year":"2013","journal-title":"Clin. Ther."},{"key":"B276","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/164_2018_185","article-title":"The nociceptin \/ orphanin FQ system and the regulation of memory.","volume":"254","author":"Moul\u00e9dous","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"B277","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1097\/J.PAIN.0000000000002235","article-title":"Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.","volume":"162","author":"Moye","year":"2021","journal-title":"Pain"},{"key":"B278","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejphar.2004.03.028","article-title":"Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.","volume":"491","author":"Murakawa","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","article-title":"Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats.","volume":"75","author":"Murphy","year":"1996","journal-title":"Neuroscience"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.3389\/FPAIN.2021.721357","article-title":"Opioids and chronic pain: an analytic review of the clinical evidence.","volume":"2","author":"Nadeau","year":"2021","journal-title":"Front. Pain Res."},{"key":"B281","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/278423a0","article-title":"Nucleotide sequence of cloned cDNA for bovine corticotropin-\u03b2- lipotropin precursor.","volume":"278","author":"Nakanishi","year":"1979","journal-title":"Nature"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2021.650785\/BIBTEX","article-title":"Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities.","volume":"15","author":"Namba","year":"2021","journal-title":"Front. Neurosci."},{"key":"B283","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/SJ.NPP.1300858","article-title":"Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.","volume":"31","author":"Narita","year":"","journal-title":"Neuropsychopharmacology"},{"key":"B284","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/J.1471-4159.2006.03824.X","article-title":"Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical \u03b4-opioid receptor dysfunction.","volume":"97","author":"Narita","year":"","journal-title":"J. Neurochem."},{"key":"B285","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.npp.1300527","article-title":"Direct evidence for the involvement of the mesolimbic \u03ba-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.","volume":"30","author":"Narita","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B286","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/J.TINS.2015.09.003","article-title":"Brain circuits encoding reward from pain relief.","volume":"38","author":"Navratilova","year":"2015","journal-title":"Trends Neurosci."},{"key":"B287","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/J.PAIN.0000000000001458","article-title":"Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.","volume":"160","author":"Navratilova","year":"2019","journal-title":"Pain"},{"key":"B288","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neuropharm.2018.11.040","article-title":"Dissociative effects of dorsomedial striatum D1 and D2 receptor antagonism in the regulation of anxiety and learned approach-avoidance conflict decision-making.","volume":"146","author":"Nguyen","year":"2019","journal-title":"Neuropharmacology"},{"key":"B289","year":"2008","journal-title":"Comorbidity: Addiction and Other Mental Illnesses."},{"key":"B290","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.TIPS.2010.04.003","article-title":"Neuropathic and chronic pain stimuli downregulate central \u03bc -opioid and dopaminergic transmission.","volume":"31","author":"Niikura","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"B291","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/J.NEULET.2008.02.059","article-title":"Direct evidence for the involvement of endogenous \u03b2-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.","volume":"435","author":"Niikura","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B292","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1523\/JNEUROSCI.1631-13.2013","article-title":"Spinal \u03bc and \u03b4 opioids inhibit both thermal and mechanical pain in rats.","volume":"33","author":"Normandin","year":"2013","journal-title":"J. Neurosci."},{"key":"B293","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0006-8993(95)00279-Y","article-title":"Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal.","volume":"683","author":"Nylander","year":"1995","journal-title":"Brain Res."},{"key":"B294","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0149-7634(79)90014-9","article-title":"Endogenous opiates: through 1978.","volume":"3","author":"Olson","year":"1979","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B295","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0306-4522(02)00699-1","article-title":"Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.","volume":"116","author":"Ozaki","year":"2003","journal-title":"Neuroscience"},{"key":"B296","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1046\/J.1471-4159.2003.02272.X","article-title":"Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.","volume":"88","author":"Ozaki","year":"2004","journal-title":"J. Neurochem."},{"key":"B297","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1046\/J.1471-4159.2002.01071.X","article-title":"Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in l-opioid receptor functions in the ventral tegmental area.","volume":"82","author":"Ozaki","year":"2002","journal-title":"J. Neurochem."},{"key":"B298","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/17512433.2019.1635454","article-title":"Buprenorphine treatment for opioid use disorder: recent progress.","volume":"12","author":"Parida","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update.","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain"},{"key":"B300","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41380-018-0117-2","article-title":"Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.","volume":"24","author":"Peci\u00f1a","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B301","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/J.DRUGALCDEP.2012.01.013","article-title":"Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR.","volume":"124","author":"Peng","year":"2012","journal-title":"Drug Alcohol. Depend."},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.11606\/S1518-8787.2017051007025","article-title":"Prevalence and clinical profile of chronic pain and its association with mental disorders.","volume":"51","author":"Pereira","year":"2017","journal-title":"Rev. Saude Publ."},{"key":"B303","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.2147\/JPR.S231948","article-title":"Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain.","volume":"12","author":"Pergolizzi","year":"2019","journal-title":"J. Pain Res."},{"key":"B304","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/SJ.BJP.0706686","article-title":"Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.","volume":"147","author":"Perrine","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1126\/SCIENCE.179.4077.1011","article-title":"Opiate receptor: demonstration in nervous tissue.","volume":"179","author":"Pert","year":"1973","journal-title":"Science"},{"key":"B306","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/J.NEUROSCIENCE.2007.03.029","article-title":"The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.","volume":"146","author":"Petraschka","year":"2007","journal-title":"Neuroscience"},{"key":"B307","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1126\/SCIENCE.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors.","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"B308","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.neuron.2015.04.015","article-title":"Role of dopamine neurons in reward and aversion: a synaptic plasticity perspective.","volume":"86","author":"Pignatelli","year":"2015","journal-title":"Neuron"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHRS.2019.104447","article-title":"Sex differences in the response to opioids for pain relief: a systematic review and meta-analysis.","volume":"148","author":"Pisanu","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B310","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-pharmtox-010715-103042","article-title":"The emerging role of spinal dynorphin in chronic pain: a therapeutic perspective.","volume":"56","author":"Podvin","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B311","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/J.NEUROPHARM.2005.11.002","article-title":"Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.","volume":"50","author":"Pol","year":"2006","journal-title":"Neuropharmacology"},{"key":"B312","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0006-8993(98)00292-3","article-title":"Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury.","volume":"795","author":"Porreca","year":"1998","journal-title":"Brain Res."},{"key":"B313","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/J.TIPS.2011.06.008","article-title":"The delta opioid receptor: an evolving target for the treatment of brain disorders.","volume":"32","author":"Pradhan","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"B314","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/J.EJPHAR.2004.07.036","article-title":"Opioid abuse and brain gene expression.","volume":"500","author":"Przewlocki","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00052","article-title":"The delta-opioid receptor; a target for the treatment of pain.","volume":"13","author":"Quirion","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1124\/pr.111.004598","article-title":"Functional selectivity at the \u03bc-opioid receptor: implications for understanding opioid analgesia and tolerance.","volume":"63","author":"Raehal","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"B317","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1016\/0014-2999(94)90073-6","article-title":"G-protein antisense oligodeoxyribonucleotides and \u03bc-opioid supraspinal antinociception.","volume":"258","author":"Raffa","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"9980","DOI":"10.1523\/JNEUROSCI.22-22-09980.2002","article-title":"The role of spinal neuroimmune activation in morphine tolerance\/hyperalgesia in neuropathic and sham-operated rats.","volume":"22","author":"Raghavendra","year":"2002","journal-title":"J. Neurosci."},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1097\/J.PAIN.0000000000001939","article-title":"The Revised IASP definition of pain: concepts, challenges, and compromises.","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"B320","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/J.BIOPSYCH.2012.06.012","article-title":"Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the \u03ba opioid agonist Salvinorin A in humans.","volume":"72","author":"Ranganathan","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B321","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1124\/JPET.103.060582","article-title":"Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.","volume":"309","author":"Rashid","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B322","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41386-018-0234-2","article-title":"Relapse to opioid seeking in rat models: behavior, pharmacology and circuits.","volume":"44","author":"Reiner","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B323","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/S00213-021-05816-9\/FIGURES\/5","article-title":"Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats.","volume":"238","author":"Reiner","year":"2021","journal-title":"Psychopharmacology"},{"key":"B324","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2021.745178\/FULL","article-title":"Delta opioid receptor in astrocytes contributes to neuropathic cold pain and analgesic tolerance in female mice.","volume":"15","author":"Reiss","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"B326","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1021\/ACSCHEMNEURO.7B00090","article-title":"Recent advances in the realm of allosteric modulators for opioid receptors for future therapeutics.","volume":"8","author":"Remesic","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"B327","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nn.4199","article-title":"The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain.","volume":"19","author":"Ren","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B328","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/J.PAIN.0000000000002092","article-title":"Adaptive alterations in the mesoaccumbal network after peripheral nerve injury.","volume":"162","author":"Ren","year":"2021","journal-title":"Pain"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-6-8","article-title":"Combined analysis of circulating \u03b2-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.","volume":"6","author":"Rhodin","year":"2013","journal-title":"Mol. Brain"},{"key":"B330","doi-asserted-by":"publisher","first-page":"3.e1","DOI":"10.1016\/B978-0-323-40196-8.00001-2","article-title":"Anatomy and physiology of the pain signaling process.","volume":"2018","author":"Ringkamp","year":"2018","journal-title":"Essent. Pain Med."},{"key":"B331","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/J.NEUBIOREV.2021.04.033","article-title":"Reward processing as a common diathesis for chronic pain and depression.","volume":"127","author":"Rizvi","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B332","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s002100000358","article-title":"Characterization of the locomotor activity-inhibiting effect of nociceptin\/orphanin FQ in mice.","volume":"363","author":"Rizzi","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B333","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/jpet.106.116780","article-title":"Pharmacological characterization of the nociceptin\/orphanin FQ receptor antagonist SB-612111 [(\u2013)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.","volume":"321","author":"Rizzi","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B334","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/J.NEUROPHARM.2010.12.010","article-title":"Nociceptin\/orphanin FQ receptor knockout rats: in vitro and in vivo studies.","volume":"60","author":"Rizzi","year":"2011","journal-title":"Neuropharmacology"},{"key":"B335","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","article-title":"Opioid-induced hyperalgesia: cellular and molecular mechanisms.","volume":"338","author":"Roeckel","year":"2016","journal-title":"Neuroscience"},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.1016\/J.ADDBEH.2019.106156","article-title":"Sex differences in the relationship between anxiety sensitivity and opioid misuse among adults with chronic pain.","volume":"102","author":"Rogers","year":"2020","journal-title":"Addict. Behav."},{"key":"B337","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u201314.","volume":"64","author":"Rudd","year":"2016","journal-title":"Morb. Mortal Wkly Rep."},{"key":"B338","author":"Saegusa","year":"2000","journal-title":"Altered Pain Responses in Mice Lacking 1E Subunit of the Voltage-Dependent Ca 2 Channel."},{"key":"B339","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2334\/josnusd.16-0874","article-title":"Mechanisms underlying \u03b4- and \u03bc-opioid receptor agonist-induced increases in extracellular dopamine level in the nucleus accumbens of freely moving rats.","volume":"59","author":"Saigusa","year":"2017","journal-title":"J. Oral Sci."},{"key":"B340","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/S00213-005-0112-6","article-title":"Role of \u03b4-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.","volume":"182","author":"Saitoh","year":"2005","journal-title":"Psychopharmacology"},{"key":"B341","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/S00213-003-1643-3","article-title":"Central administration of nociceptin\/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.","volume":"172","author":"Sakoori","year":"2004","journal-title":"Psychopharmacology"},{"key":"B342","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/J.1399-6576.1993.TB03755.X","article-title":"CSF neuropeptides in cancer pain: effects of spinal opioid therapy.","volume":"37","author":"Samuelsonn","year":"1993","journal-title":"Acta Anaesthesiol. Scand."},{"key":"B343","doi-asserted-by":"publisher","first-page":"19384","DOI":"10.1523\/JNEUROSCI.1979-13.2013","article-title":"Long-term antagonism of \u03ba opioid receptors prevents escalation of and increased motivation for heroin intake.","volume":"33","author":"Schlosburg","year":"2013","journal-title":"J. Neurosci."},{"key":"B344","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1097\/J.PAIN.0000000000000633","article-title":"Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.","volume":"157","author":"Schrepf","year":"2016","journal-title":"Pain"},{"key":"B345","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.1253994","article-title":"Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens.","volume":"345","author":"Schwartz","year":"2014","journal-title":"Science"},{"key":"B346","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.peptides.2009.12.028","article-title":"Selective inhibition of the NOP receptor in the ventrolateral periaqueductal gray attenuates the development and the expression of tolerance to morphine-induced antinociception in rats.","volume":"31","author":"Scoto","year":"2010","journal-title":"Peptides"},{"key":"B347","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROPHARM.2020.107935","article-title":"Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.","volume":"166","author":"Selley","year":"2020","journal-title":"Neuropharmacology"},{"key":"B348","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1213\/ANE.0B013E3182025B15","article-title":"Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats.","volume":"112","author":"Shen","year":"2011","journal-title":"Anesth. Analg."},{"key":"B349","author":"Shenoy","year":"2018","journal-title":"Biochemistry, Endogenous Opioids."},{"key":"B350","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/J.EJPHAR.2007.09.042","article-title":"PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.","volume":"579","author":"Shi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B351","first-page":"648","article-title":"d-methadone is antinociceptive in the rat formalin test.","volume":"283","author":"Shimoyama","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B352","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/J.NEUROPHARM.2005.04.008","article-title":"The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference.","volume":"49","author":"Shoblock","year":"2005","journal-title":"Neuropharmacology"},{"key":"B353","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1097\/ADM.0000000000000630","article-title":"Secondary analysis of pain outcomes in a large pragmatic randomized trial of buprenorphine\/naloxone versus methadone for opioid use disorder.","volume":"14","author":"Shulman","year":"2020","journal-title":"J. Addict. Med."},{"key":"B354","doi-asserted-by":"publisher","first-page":"679","DOI":"10.36076\/ppj.2009\/12\/679","article-title":"Opioid induced hyperalgesia: clinical implications for the pain practitioner.","volume":"12","author":"Silverman","year":"2009","journal-title":"Pain Phys."},{"key":"B355","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1073\/pnas.70.7.1947","article-title":"Stereospecific binding of the potent narcotic analgesic [3H] etorphine to rat brain homogenate (opiate receptor\/morphine\/antagonist).","volume":"70","author":"Simon","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B356","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.coph.2016.11.007","article-title":"Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics.","volume":"32","author":"Siuda","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"B357","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","article-title":"Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists.","volume":"59","author":"Sj\u00f8gren","year":"1994","journal-title":"Pain"},{"key":"B358","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/BPH.14899","article-title":"The nociceptin\/orphanin FQ receptor system as a target to alleviate cancer-induced bone pain in rats: model validation and pharmacological evaluation.","volume":"178","author":"Sliepen","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B359","doi-asserted-by":"publisher","DOI":"10.1016\/J.PSYCHRES.2020.113523","article-title":"Anxiety sensitivity and pain intensity independently predict opioid misuse and dependence in chronic pain patients.","volume":"294","author":"Smit","year":"2020","journal-title":"Psychiatry Res."},{"key":"B360","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/EJP.1755","article-title":"Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study.","volume":"25","author":"Soares","year":"2021","journal-title":"Eur. J. Pain"},{"key":"B361","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/J.BRAINRES.2008.12.002","article-title":"Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration.","volume":"1255","author":"Solecki","year":"2009","journal-title":"Brain Res."},{"key":"B362","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/SCIENCE.AAI8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations.","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"key":"B363","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/PNAS.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B364","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES27030595","article-title":"Spotlight on nociceptin\/orphanin FQ receptor in the treatment of pain.","volume":"27","author":"Spetea","year":"2022","journal-title":"Molecules"},{"key":"B365","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/S11606-021-07119-3\/TABLES\/2","article-title":"Rapid discontinuation of chronic, high-dose opioid treatment for pain: prevalence and associated factors.","volume":"37","author":"Stein","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"B366","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/J.EJPHAR.2013.01.076","article-title":"Opioids, sensory systems and chronic pain.","volume":"716","author":"Stein","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B367","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/ANNUREV-MED-062613-093100","article-title":"Opioid receptors.","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"B368","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainresrev.2008.12.017","article-title":"Peripheral mechanisms of pain and analgesia.","volume":"60","author":"Stein","year":"2009","journal-title":"Brain Res. Rev."},{"key":"B369","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nm908","article-title":"Attacking pain at its source: new perspectives on opioids.","volume":"9","author":"Stein","year":"2003","journal-title":"Nat. Med."},{"key":"B370","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1124\/jpet.104.082685","article-title":"Interactions between \u03b4 and \u03bc opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(\u03b1R)-\u03b1-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl) -3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.","volume":"314","author":"Stevenson","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B371","doi-asserted-by":"publisher","first-page":"963.e5","DOI":"10.1016\/j.neuron.2018.04.021","article-title":"A genetically encoded biosensor reveals location bias of opioid drug action.","volume":"98","author":"Stoeber","year":"2018","journal-title":"Neuron"},{"key":"B372","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/pm\/pnaa029","article-title":"Outcomes in long-term opioid tapering and buprenorphine transition: a retrospective clinical data analysis.","volume":"21","author":"Sturgeon","year":"2020","journal-title":"Pain Med."},{"key":"B373","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4036-14.2015","article-title":"Microglia disrupt mesolimbic reward circuitry in chronic pain.","volume":"35","author":"Taylor","year":"2015","journal-title":"J. Neurosci."},{"key":"B374","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction.","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"B375","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/J.BRAINRES.2018.09.023","article-title":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: implications for negative affective states and psychiatric disorders.","volume":"1713","author":"Tejeda","year":"2019","journal-title":"Brain Res."},{"key":"B376","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/npp.2013.76","article-title":"Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.","volume":"38","author":"Tejeda","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B377","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neuron.2016.12.005","article-title":"Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity.","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron"},{"key":"B378","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1600-0773.1973.tb01477.x","article-title":"Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex.","volume":"32","author":"Terenius","year":"1973","journal-title":"Acta Pharmacol. Toxicol."},{"key":"B379","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1097\/J.PAIN.0000000000001282","article-title":"Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat.","volume":"159","author":"Thompson","year":"2018","journal-title":"Pain"},{"key":"B380","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/PR.114.009209","article-title":"Nociceptin\/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems.","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"B381","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2005.11.005","article-title":"Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats.","volume":"1069","author":"Torregrossa","year":"2006","journal-title":"Brain Res."},{"key":"B382","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0000000000000409","article-title":"The endogenous opioid system: role and dysfunction caused by opioid therapy.","volume":"62","author":"Toubia","year":"2019","journal-title":"Clin. Obstet. Gynecol."},{"key":"B383","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/J.METABOL.2010.07.015","article-title":"Genetics of pain, opioids, and opioid responsiveness.","volume":"59","author":"Tremblay","year":"2010","journal-title":"Metabolism"},{"key":"B384","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0006-8993(95)00809-5","article-title":"Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides.","volume":"698","author":"Trujillo","year":"1995","journal-title":"Brain Res."},{"key":"B385","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ana.10465","article-title":"\u03bc Opioid receptors and analgesia at the site of a peripheral nerve injury.","volume":"53","author":"Truong","year":"2003","journal-title":"Ann. Neurol."},{"key":"B386","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/papr.12558","article-title":"Antihyperalgesic, antiallodynic, and antinociceptive effects of cebranopadol, a novel potent nociceptin\/orphanin FQ and opioid receptor agonist, after peripheral and central administration in rodent models of neuropathic pain.","volume":"17","author":"Tzschentke","year":"2017","journal-title":"Pain Pract."},{"key":"B387","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/164_2019_206","article-title":"Cebranopadol: a novel first-in-class potent analgesic acting via NOP and opioid receptors.","volume":"254","author":"Tzschentke","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"B388","year":"2019","journal-title":"Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations."},{"key":"B389","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0304-3940(97)00832-X","article-title":"Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene.","volume":"237","author":"Ueda","year":"1997","journal-title":"Neurosci. Lett."},{"key":"B390","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/SJ.BJP.0700971","article-title":"The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man.","volume":"120","author":"Ur","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"B391","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function.","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B392","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1523\/jneurosci.21-01-00279.2001","article-title":"Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance.","volume":"21","author":"Vanderah","year":"2001","journal-title":"J. Neurosci."},{"key":"B393","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROPHARM.2020.108226","article-title":"Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain.","volume":"178","author":"Vergara","year":"2020","journal-title":"Neuropharmacology"},{"key":"B394","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/J.JPAIN.2017.08.011","article-title":"Previous mental disorders and subsequent onset of chronic back or neck pain: findings from 19 countries.","volume":"19","author":"Viana","year":"2018","journal-title":"J. Pain"},{"key":"B395","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/ANNUREV-MED-011817-044739","article-title":"Use and misuse of opioids in chronic pain.","volume":"69","author":"Volkow","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"B396","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMRA1507771","article-title":"Opioid abuse in chronic pain \u2014 misconceptions and mitigation strategies.","volume":"374","author":"Volkow","year":"2016","journal-title":"New Engl. J. Med."},{"key":"B397","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/J.EURONEURO.2019.10.014","article-title":"The effects of nalmefene on emotion processing in alcohol use disorder - A randomized, controlled fMRI study.","volume":"29","author":"Vollst\u00e4dt-Klein","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B398","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13011-017-0120-7\/TABLES\/3","article-title":"Chronic pain and opioid misuse: a review of reviews.","volume":"12","author":"Voon","year":"2017","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"B399","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"B400","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079239","article-title":"Effect of chronic pain on fentanyl self-administration in mice.","volume":"8","author":"Wade","year":"2013","journal-title":"PLoS One"},{"key":"B401","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-019-44497-5","article-title":"Altered functional connectivity associated with time discounting in chronic pain.","volume":"9","author":"Wakaizumi","year":"2019","journal-title":"Sci. Rep."},{"key":"B402","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1097\/00001756-199807130-00017","article-title":"Nociceptin fails to affect heroin self-administration in the rat.","volume":"9","author":"Walker","year":"1998","journal-title":"Neuroreport"},{"key":"B403","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses.","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"B404","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/J.JPAIN.2021.08.005","article-title":"NIH\u2019s helping to end addiction long-termSM initiative (NIH HEAL initiative) clinical pain management common data element program.","volume":"23","author":"Wandner","year":"2022","journal-title":"J. Pain"},{"key":"B405","doi-asserted-by":"publisher","first-page":"90.e5","DOI":"10.1016\/J.NEURON.2018.03.002","article-title":"Functional divergence of Delta and Mu opioid receptor organization in CNS pain circuits.","volume":"98","author":"Wang","year":"2018","journal-title":"Neuron"},{"key":"B406","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2147\/JIR.S266995","article-title":"Spinal TLR4\/P2X7 receptor-dependent NLRP3 inflammasome activation contributes to the development of tolerance to morphine-induced antinociception.","volume":"13","author":"Wang","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"B407","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/J.NEUROSCIENCE.2005.06.003","article-title":"Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor\u2013G protein coupling and G\u03b2\u03b3 signaling.","volume":"135","author":"Wang","year":"2005","journal-title":"Neuroscience"},{"key":"B408","first-page":"107","article-title":"Methadone maintenance treatment","author":"Ward","year":"2009","journal-title":"Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness, and Implementation Guidelines"},{"key":"B409","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0169-328X(96)00084-8","article-title":"Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus.","volume":"41","author":"Wardlaw","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B410","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/S12640-020-00166-4","article-title":"Neuropathic pain dysregulates gene expression of the forebrain opioid and dopamine systems.","volume":"37","author":"Wawrzczak-Bargie\u0142a","year":"2020","journal-title":"Neurotox Res."},{"key":"B411","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1152\/PHYSREV.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence.","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"key":"B412","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/J.1526-4637.2007.00401.X","article-title":"Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department.","volume":"9","author":"Wilsey","year":"2008","journal-title":"Pain Med."},{"key":"B413","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/J.PHARMTHERA.2013.10.011","article-title":"The biology of Nociceptin\/Orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.","volume":"141","author":"Witkin","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B414","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1089\/neu.2013.3293","article-title":"Morphine Self-Administration following Spinal Cord Injury.","volume":"31","author":"Woller","year":"2014","journal-title":"J. Neurotrauma"},{"key":"B415","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1037\/PHA0000039","article-title":"Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.","volume":"23","author":"Worley","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"B416","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/add.13782","article-title":"Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.","volume":"112","author":"Worley","year":"2017","journal-title":"Addiction"},{"key":"B417","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1523\/JNEUROSCI.5552-03.2004","article-title":"Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.","volume":"24","author":"Xu","year":"2004","journal-title":"J. Neurosci."},{"key":"B418","first-page":"2092","article-title":"Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ\/nociceptin in the rat.","volume":"7","author":"Xu","year":"1996","journal-title":"Neuroreport"},{"key":"B419","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0306-4522(97)00166-8","article-title":"Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like receptor agonist, in the rat formalin test.","volume":"81","author":"Yamamoto","year":"1997","journal-title":"Neuroscience"},{"key":"B420","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1073\/pnas.90.14.6736","article-title":"Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.","volume":"90","author":"Yasuda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B421","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/APPI.AJP.2015.15040535","article-title":"Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial.","volume":"173","author":"Yovell","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"B422","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1215\/00703370-8977691","article-title":"Pain trends among american adults, 2002\u20132018: patterns, disparities, and correlates.","volume":"58","author":"Zajacova","year":"2021","journal-title":"Demography"},{"key":"B423","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00638","article-title":"The nociceptin receptor (NOP) agonist AT-312 blocks acquisition of morphine- and cocaine-induced conditioned place preference in mice.","volume":"9","author":"Zaveri","year":"2018","journal-title":"Front. Psychiatry"},{"key":"B424","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000103923","article-title":"Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.","volume":"80","author":"Zernig","year":"2007","journal-title":"Pharmacology"},{"key":"B425","first-page":"551","article-title":"Tolerance of hypothalamic \u03b2-endorphin neurons to \u03bc-opioid receptor activation after chronic morphine.","volume":"277","author":"Zhang","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B426","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/SJ.MP.4002035","article-title":"The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.","volume":"13","author":"Zhang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"B427","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0306-4522(97)00240-6","article-title":"Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy.","volume":"82","author":"Zhang","year":"1998","journal-title":"Neuroscience"},{"key":"B428","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55289","article-title":"Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids.","volume":"9","author":"Zhang","year":"2020","journal-title":"eLife"},{"key":"B429","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ETM.2021.10437","article-title":"Molecular mechanisms of opioid tolerance: from opioid receptors to inflammatory mediators (Review).","volume":"22","author":"Zhou","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"B430","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(00)80836-3","article-title":"Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice.","volume":"24","author":"Zhu","year":"1999","journal-title":"Neuron"},{"key":"B431","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-540-33823-9_2","article-title":"Opioids.","volume":"177","author":"Z\u00f6llner","year":"2007","journal-title":"Handb. Exp. Pharmacol."},{"key":"B432","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional Mu opioid receptor regulation of sensory and affective dimensions of pain.","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"},{"key":"B433","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1523\/jneurosci.22-12-05100.2002","article-title":"\u03bc-opioid receptor-mediated antinociceptive responses differ in men and women.","volume":"22","author":"Zubieta","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Frontiers in Systems Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnsys.2022.1014768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:49:39Z","timestamp":1666169379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnsys.2022.1014768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":433,"alternative-id":["10.3389\/fnsys.2022.1014768"],"URL":"https:\/\/doi.org\/10.3389\/fnsys.2022.1014768","relation":{},"ISSN":["1662-5137"],"issn-type":[{"value":"1662-5137","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"article-number":"1014768"}}